(Q37505027)

20 August 2017

Can intranasal drug use reduce HCV infection among injecting drug users? (English)

1 reference

20 August 2017

2

Holly Hagan

0 references

Don C Des Jarlais

series ordinal

1

object named as

Don C Des Jarlais

1 reference

20 August 2017

6

David C Perlman

1 reference

20 August 2017

3

Kamyar Arasteh

1 reference

20 August 2017

4

Courtney McKnight

1 reference

20 August 2017

5

Salaam Semaan

1 reference

20 August 2017

26 July 2011

1 reference

Drug and Alcohol Dependence

20 August 2017

1 reference

20 August 2017

119

1 reference

20 August 2017

3

1 reference

20 August 2017

201-206

1 reference

A systematic review and meta-analysis of interventions to prevent hepatitis C virus infection in people who inject drugs

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Route transition interventions: potential public health gains from reducing or preventing injecting

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Meta-regression of hepatitis C virus infection in relation to time since onset of illicit drug injection: the influence of time and place

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Volunteer bias in nonrandomized evaluations of the efficacy of needle-exchange programs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Expected increase in prevalence of HCV-related cirrhosis and its complications in the United States: no effect of current antiviral treatment coverage?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Attribution of hepatitis C virus seroconversion risk in young injection drug users in 5 US cities

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Incidence and risk factors of HCV and HIV infections in a cohort of intravenous drug users in the North and East of France

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Hepatitis C: Enhancing treatment for hepatitis C among drug users.

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

HCV reinfection studies and the door to vaccine development.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Transitions in drug use in a new generation of problem drug users in Amsterdam: a 6-year follow-up study.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Frequent needle exchange use and HIV incidence in Vancouver, Canada.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990-2001.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Keeping it together: stigma, response, and perception of risk in relationships between drug injectors and crack smokers, and other community residents

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

The impact of injecting drug use status on hepatitis C-related referral and treatment

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Can drug injectors be encouraged to adopt non-injecting routes of administration (NIROA) for drugs?

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Changes in route of drug administration among continuing heroin users: outcomes 1 year after intake to treatment.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

The transition from injecting to smoking heroin in three Spanish cities. The Spanish Group for the Study of the Route of Heroin Administration

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Decline in intravenous drug use among treatment-seeking opiate users

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

AIDS and the transition to illicit drug injection--results of a randomized trial prevention program

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5157129

Sharing of drug preparation equipment as a risk factor for hepatitis C

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21794991

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21794991

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.DRUGALCDEP.2011.06.020

1 reference

20 August 2017

1 reference

PMC publication ID

5157129

20 August 2017

PubMed publication ID

21794991

1 reference

PMC publication ID

5157129